Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01185 (
vasopressin
)
23,126
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A number of candidate mammalian prohormone processing enzymes related to the yeast Kex2 endoprotease have been cloned and demonstrated to cleave several prohormone precursors at single, pairs and tetra basic amino acid processing sites. We have mapped the distribution of the mRNAs encoding two of these endoproteases in adult rat brain.
SPC3
message levels showed a more restricted distribution and generally lower levels than SPC2 transcripts. The highest levels of SPC2 mRNA were found in the pyramidal cells of the hippocampus, several thalamic nuclei, the habenula and selected nuclei in the hypothalamus.
SPC3
mRNA was most abundant in dentate gyrus granule cells, the habenula and selected hypothalamic nuclei. In the hypothalamus overlapping and unique distributions of the two transcripts were seen in the paraventricular nucleus with
SPC3
mRNA predominantly expressed in lateral magnocellular cells. Both SPC2 and
SPC3
mRNA were upregulated in the paraventricular and supraoptic hypothalamic nuclei following chronic salt loading. Combined immunocytochemistry/in situ hybridization histochemistry demonstrated that SPC2 and
SPC3
transcripts were both expressed in the vasopressinergic subpopulation of magnocellular neurons in the supraoptic nucleus.
SPC3
mRNA, but not SPC2 transcripts, also colocalized with immunoreactive
vasopressin
-associated neurophysin in the suprachiasmatic nucleus. These results remain consistent with roles for SPC2 and
SPC3
in the biosynthesis of neuropeptides and for a specific role for
SPC3
in the processing of provasopressin. Increased levels of SPC2 and
SPC3
transcripts following a chronic osmotic stimulus suggests these proteases are coregulated with prohormone substrates and may be useful as an indicator of peptidergic activity.
...
PMID:Distribution and regulation of the candidate prohormone processing enzymes SPC2 and SPC3 in adult rat brain. 789 39
We have investigated the roles of full-length and carboxyl-terminus-truncated forms of the subtilisin-like prohormone convertase
SPC3
in the processing of the radiolabeled
vasopressin
and oxytocin precursors, in vitro. We found
SPC3
cleaves provasopressin at both the
vasopressin
-neurophysin and neurophysin-glycopeptide processing sites. Prooxytocin is cleaved by
SPC3
at the oxytocin-neurophysin cleavage site. However, our results reveal differences in processing of provasopressin by the different molecular forms of
SPC3
. In incubations where the rate of autocatalytic carboxyl-terminus truncation of
SPC3
was dramatically reduced, 86-kDa
SPC3
, which has an unprocessed carboxyl terminus, cleaved provasopressin at the neurophysin-glycopeptide junction. Cleavage at the
vasopressin
-neurophysin junction only occurred with the appearance of carboxyl-terminus-truncated forms of the enzyme. Incubations containing 64-kDa
SPC3
or 64-kDa
SPC3
-T, a recombinant form of
SPC3
truncated 14 amino acids beyond the conserved carboxyl-terminal "P-domain," rapidly cleaved provasopressin at both the
vasopressin
-neurophysin and neurophysin-glycopeptide junctions. Our results also suggest that prooxytocin is unable to be cleaved by the 86-kDa form of
SPC3
. We propose that
SPC3
should be considered as a candidate endoprotease in the biosynthesis of
vasopressin
. Furthermore, we suggest that the carboxyl terminus of
SPC3
alters the cleavage specificity of
SPC3
.
...
PMID:Differential cleavage of provasopressin by the major molecular forms of SPC3. 952 85